Evaluation of adverse events of bamlanivimab, bamlanivimab/etesevimab used for COVID-19 based on FAERS database

Zhao, YF; Wang, HL; Zhang, QS; Hu, YX; Xu, YL; Liu, W

Liu, W (通讯作者)，Zhengzhou Univ, Sch Pharmaceut Sci, Dept Pharmaceut, Zhengzhou, Peoples R China.

EXPERT OPINION ON DRUG SAFETY, 2023; 22 (4): 331

Abstract

Background We study the adverse events (AEs) of bamlanivimab (BAM), bamlanivimab/etesevimab (BAM/ETE) to alert risk factors during coronavirus disease......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索